1. James WD, Berger TG, Elston DM.

Chapter 10 Seborrheic Dermatitis, Psoriasis,

Recalcitrant Palmoplantar Eruptions, Pustular Dermatitis, and Erythroderma.
In:Andrew’s Diseases of The Skin: Clinical Dermatology 12th Eds. Philadelphia:
Elsevier. 2016: 185-198.

2. Menaldi SL, Bramono K, Indriatmmi W, Ilmu Penyakit Kulit dan Kelamin edisi ke-7,
Jakarta : Balai Penerbit FK UI, 2015:213-221.

3. Gudjonsson, Johann E., Elder, T. J. Psoriasis. Dalam Fitzpatrick’s Dermatology in

General Medicine Eighth Eds. Goldsmith La, Katz SI, Gilchrest BA, Paller AS, Leffell
DJ, Wolff K, editors. New York: McGraw-Hill, 2012:197-231.

4. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a
systematic review of incidence and prevalence. Journal of Investigative Dermatology.
2013;133(2):377-85.

5. Grace W, Chairiyah T, Irma D. R. Profil Kadar Vascular Endothelial Growth Factor

(Vegf) Serum berdasarkan Karakteristik Pasien Psoriasis Vulgaris di RSUP H. Adam
Malik Medan. Artikel MDVI PERDOSKI. 2017;44(14);8 -14

6. Alyssa AV, Athuf T, Mutia D. Angka Kejadian Psoriasis Vulgaris di Poliklinik Ilmu
Kesehatan Kulit dan Kelamin RSUP dr. Mohammad Hoesin Palembang Periode Agustus
2008–Juni 2012. MKS. E-Journal Unsri. 2014;46(4):253-258

7. WHO. Global report on psoriasis. World Health Organization, 2016. Available from
www.who.int.

8. Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis: a

comprehensive review. Journal of autoimmunity. 2015;64:66-73.

9. Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of

psoriasis. Autoimmunity reviews. 2014;13(4):490-5.

10. Whan BK, Dana J, Jensen Y. Diagnosis and Management of Psoriasis. Clinical Review
Canadian Family Physician. 2017;63;278-285

11. Nast A, Gisondi P, Ormerod AD, Saiag P, Smith C, Spuls PI, Arenberger P, Bachelez H,
Barker J, Dauden E, Jong EM. European S3‐Guidelines on the systemic treatment of
psoriasis vulgaris–Update 2015–Short version–EDF in cooperation with EADV and IPC.
Journal of the European Academy of Dermatology and Venereology. 2015;29(12):2277-
94.

12. Choon SE, Chan LC, Choon SE, Jamil A, Chin CL, Cheng CH, Ambrose D, Majid HA,
Heng KC, Lin LY, Yusof MA. Malaysian Clinical Practice Guideline for the
Management of Psoriasis Vulgaris: Summary of recommendations for management in
primary healthcare setting. Journal of the Academy of Family Physicians of Malaysia.
2014;9(1):16.

13. Jeung CY, Ho KM. Evaluation of patients' topical treatment adherence, psychosocial
impact, satisfaction with disease control and disease knowledge among patients with
 psoriasis vulgaris: a pilot study in Hong Kong. Hong Kong Journal Of Dermatology &
Venereology. 2016 ;24(4):173-83.

14. Kolios AG, Yawalkar N, Anliker M, Boehncke WH, Borradori L, Conrad C, Gilliet M,
Häusermann P, Itin P, Laffitte E, Mainetti C. Swiss S1 guidelines on the systemic
treatment of psoriasis vulgaris. Dermatology. 2016;232(4):385-406.

15. Kenneth A, Philip E, Bruce E. New Treatment Paradigm in Psoriasis: Understanding and
Incorporating Recent and Emerging Trends. Seminars in Cutaneous Medicine and
Surgery: Frontline Medical Communications Inc. 2018; 37(2);39-59